Dr Dorna Esrafilzadeh is a Scientia Senior Lecturer and ARC DECRA fellow at the School of Biomedical Engineering, UNSW, Sydney. She leads the Materials and Fabrication research group, focusing on advanced materials chemistry, nanotechnology, and additive manufacturing for environmental and biomedical applications. Her research is particularly recognised for pioneering work in electromaterials and liquid metal-based systems, including their use in electrocatalysis, CO₂ conversion, and flexible bioelectronics.

Dr Esrafilzadeh completed her PhD at the Intelligent Polymer Research Institute (IPRI), University of Wollongong, in 2014 where she developed electroactive 3D fibrous-based electrode structures for various applications. She subsequently held research fellowships at the ARC Centre of Excellence for Electromaterials Science (ACES) and the Faculty of Engineering at RMIT University, collaborating on multidisciplinary projects to develop flexible electrodes derived from a wide range of liquid metals and semiconductors for bioelectronics, catalysis, and CO₂ conversion systems.

Her translational research has led to IP development and industry partnerships with Chevron, Cochlear, Ha Tech Ltds, securing over $6.4M in competitive funding and the development of prototype technologies. She is also the co-founder of LM⁺, a spin-out company focused on commercialising liquid metal innovations for sustainable technologies.

Dr Esrafilzadeh is a recipient of prestigious fellowships, including the ARC DECRA and UNSW Scientia. Her works have been published in top-tier journals such as Nature Communications and Nature Electronics and featured in global media outlets. She is deeply committed to training the next generation of engineers and scientists, as demonstrated through her teaching and HDR supervision activities. She has supervised numerous PhD, honours, and undergraduate students, many of whom have gone on to successful careers in academia and industry. She is an active member of national and international professional bodies, including the American Chemical Society (ACS), and contributes to science outreach, peer review, and policy development.